Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

REIMAGINE trials demonstrate efficacy of combination therapy for treating type 2 diabetes

New weight loss pill beats oral Ozempic in major trial

Farxiga Affordability Tips: From Discount Cards to Patient Assistance

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

A new triple hormone drug called retatrutide, which mimics GLP-1, GIP, and glucagon, has shown promising results in a Lancet-published trial

GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)

FDA Approves Foundayo (orforglipron): The First Oral GLP-1 Weight Loss Pill Without Fasting Requirements

The FDA approved Foundayo (orforglipron), a new once-daily oral GLP-1 weight loss pill by Eli Lilly, on April 1, 2026. Unlike other oral GLP